Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine

NCT05861427 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

523

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Atogepant
DRUG: Placebo for Atogepant

Sponsor

AbbVie